Five year treatment with IGF-I of a patient with laron syndrome in slovenia (a follow-up report)

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue 4, 1997, Pages 443-447

  Krzisnik C ^a   Battelino, T ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CLINICAL FEATURE; EXON; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LARON SYNDROME; MALE; NONSENSE MUTATION; OBESITY; TREATMENT PLANNING; YUGOSLAVIA;

EID: 0030826150     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1997.10.4.443     Document Type: Article

References (25)

1. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci 1966; 2: 152-155.
2. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968; 4: 883-894.
3. Laron Z. An update on Laron syndrome. Arch Dis Child 1993; 68: 345-346.
4. Amselen S, Sobrier ML, Duquesnoy P, Rappoport R, Postel-Vinnay MC, Gourmelen M, Dallapiccola B, Goossens M. Recurrent nonsense mutation in the GH receptor from patients with Laron dwarfism. J Clin Invest 1991; 87: 1098-1102.
5. Rosenfeld RG, Rosenbloom AL, Guevara-Arguirre J. Growth hormone insensitivity and growth hormone receptor deficiency. Endocr Rev 1994; 15: 369-390.
6. Amselem S, Sobrier ML, Dastot F, Dusquesnoy P, Duriez B, Goossens M. Molecular basis of inherited growth hormone resistance in childhood. In: Ross RJM, Savage MO, eds. Clinical Endocrinology and Metabolism. Growth Hormone Resistance. London: Baillere's 1996; 10(3): 353-370.
7. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Acta Paediatr 1994; Suppl 399: 117-124.
8. Laron Z. Laron-type dwarfism (hereditary somatomedin deficiency): a review. In: Frick P, von Hamack GA, Kochsiek K, Martini GA, Prader A, eds. Advances in Internal Medicine and Pediatrics. Berlin: Springer-Verlag, 1984; 117-150.
9. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotteril AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993; 77: 1465-1471.
10. Laron Z. Laron syndrome from description to therapy. Endocrinologist 1993; 3: 21-28.
11. Rosenbloom AL, Guevara-Aguirre J. Bienvenidos a mi tierra de soledad: from poetry to molecular biology in Southern Ecuador. J Clin Endocrinol Metab 1994; 797: 695-702.
12. Krzisnik C, Silbergeld A, Laron Z. A case of Laron syndrome diagnosed in Slovenia. J Pediatr Endocrinol 1994; 7: 365-369.
13. Rosenbloom AL, Berg MA, Kasatkina EP, Volkova TN, Skorobogatova VF, Sokolovskaya VN, Francke U. Severe growth hormone insensitivity (Laron syndrome) due to nonsense mutation of the GH receptor in brothers from Russia. J Pediatr Endocrinol Metab 1995; 8: 159-165.
14. Laron Z, Sorel R, Pertzelan A. Puberty in Laron-type dwarfism. Eur J Pediatr 1980; 134: 117-150.
15. Laron Z, Klinger B, Erster B, Anin S. Effect of acute administration of insulin-like growth factor 1 in patients with Laion-type dwarfism. Lancet 1988; 2: 1170-1172.
16. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism. Lancet 1992; 339: 1258-1261.
17. Laron Z. One-year treatment with IGF-I of children with Laron syndrome. Clin Courier 1993; 11: 7-8.
18. Klinger B, Laron Z. Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab 1995; 8: 149-158.
19. Walker J, Van Wyk JJ, Underwood LE. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type). J Pediatr 1992; 212: 641-646.
20. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF, Wilton P for the Pharmacia Study Group. Insulin-like growth factor I improves growth hormone insensitivity: two years' results. Horm Res 1995; 44: 253-264.
21. Sobrier ML, Dastot F, Duquesnoy P, Kandemir N, Yordam N, Goossens M, Amselem S. Nine novel growth hormone receptor gene mutations in patients with Laron syndrome. J Clin Endocrinol Metab 1997; 82: 435-437.
22. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. Part I, II. Arch Dis Child 1966; 445-471, 613-635.
23. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
24. Ballard FJ, Walton PE, Durshea FR, Francis GL, Tomas FM. Does IGF-I ever act through the insulin receptor? In: Baxter RG, Gluckman PD, Rosenfeld RG, eds. The Insulin-like Growth Factors and their Regulatory Proteins. Amsterdam: Excerpta Medica, 1994; 131-141.
25. Zapf J, Schoenle E, Waldvogel M, Sand I, Froesch ER. Effects of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors. Further evidence for the action of insulin-like growth factors through the insulin receptor. Eur J Biochem 1981; 113: 605-609.